During a prospective study of infectious gastroenteritis in children under 2 years, 19 out of 390 patients (4 9%) were found to have Clostridium difficile cytotoxin in the faeces. In several there was no history of use of antibiotics. The symptoms of many infants with toxin settled spontaneously, but one child became acutely and severely ill and developed a toxic megacolon and five others required, and responded to, vancomycin.
Introduction
Clostridium difficile is a well established cause of sporadic diarrhoea in adults. Usually the condition is associated with use of antibiotics but it may occur spontaneously.' 2 The organism is detectable in up to half of all healthy infants, and occasionally its cytotoxin may be found in infants in the absence of symptoms.3 In certain circumstances a devastating illness with florid pseudomembranous colitis occurs, which may prove fatal. 4 We decided to culture stools routinely for the organism and to screen for the toxin as part of a prospective study of children admitted with infectious gastroenteritis over a 12 month period; full details of the prospective study are reported separately5 (M E Ellis, Barbara Watson, B K Mandal et al, to be published).
Subjects and methods
During December 1981 to November 1982, 447 children aged under 2 years were admitted to the Regional Infectious Diseases Unit, Monsall Hospital, with infectious gastroenteritis. A detailed questionnaire was administered verbally to the mother within 24 hours of admission. In particular details of antibiotic administration within the previous two months were recorded.
A total of 118 children under 2 years with non-gastrointestinal illness admitted over the same period served as a control group. Samples of faeces obtained on admission were cultured for bacteria and viruses, and electron microscopy for viruses was also performed; techniques were as described5 (Ellis et 6:7 10* 9t 6-9 (7-1) [2-281 5-5 (7-1) [0-281 6-6 (2-2) 3 § * Rotavirus (n = 5); adenovirus (n = 6); Escherzchia coli 018 (n = 1); calicivirus (n = 1); Coxsackie virus A9 (n = 1).
t None (n = 5); erythromycin (n = 2); amoxycillin (n = 5); streptomycin (n = 1); penicillin (n = 1); cephalosporin (n = 4); ampicillin (n = 1).
I Control patients: chickenpox + mastoiditis + bronchitis (n = 1); tonsillitis (n 1); whooping cough + otitis media + pneumonia (n = 1). § Co-trimoxazole + ampicillin + flucloxacillin + erythromycin + fusidic acid (n 1); ampicillin, two courses (n = 1); co-trimoxazole for three weeks (n = 1).
Of the remaining 172 cytotoxin negative but culture positive patients in the gastroenteritis group, 129 (75",') had toxigenic and 43 (25",) non-toxigenic organisms. Of the remaining 36 controls, 19 (540)' had toxigenic and 17 (46%) non-toxigenic organisms. There were no significant clinical differences between the culture positive and culture negative groups, and within the culture positive group the presence of toxigenicity was not associated with any specific illness or a more severe illness.
Despite the greater use of antibiotics in the control group, the incidence of positive Cl difficile isolation was in fact less in this group (table I) . Erythromycin was used two and a half times more frequently in the control group as opposed to a two and a half fold greater use of penicillins and co-trimoxazole by the gastroenteritis group (table III) . Table IV shows the detailed analysis for groups more closely matched for age. Up to half of the children in our study had Cl difficile isolated from the stool with no associated faecal toxin; this has been noted before. The absence of any clinical differences between those who do and those who do not have the organism (and whether toxigenic or non-toxigenic in vitro) and a similar incidence of isolation of the organism among controls support the notion that the presence of Cl difficile alone and without demonstrable faecal toxin is not primarily pathogenic. The lesser incidence of the organism in our control group despite a threefold increase in antibiotic usage is of interest and confirms the findings of the Swedish group who found that Cl difficile occurred numerically more often in children who had not been treated by antibiotics than in those who had been given such drugs.8 This may be related to the more frequent use of the antianaerobic antibiotic erythromycin in the controls. Alternatively children who have gastroenteritis may be more prone to Cl difficile associated diarrhoea and colitis. Thus other microorganisms are found in three quarters of patients (Ellis et al, to be published); the incidence of toxin in our gastroenteritis group was twice that of the controls; and parallel experience from adult cases suggests that disturbance in bowel function due to causes other than antibiotics may also predispose to Cl difficile diarrhoea.2
The role of Cl difficile cytotoxin in children with gastroenteritis is not totally clear; many recover spontaneously, whereas the clinical condition of others demands treatment, to which they apparently respond. For children who are not that ill guidelines for treatment are lacking. Sigmoidoscopic and histological appearances of the rectal mucosa may be normal (especially if the disease is proximal) or non-specific; and toxin titres often bear little relation to severity of the disease. In view of the disastrous consequences of failure to treat some cases4 it seems prudent to treat all children who have symptoms and toxin in the stool with at least five days of oral vancomycin.
We are most grateful to D M Jones, director of the Public Health Laboratory, Withington, for his generous contribution of the use of the laboratory facilities in this study. We also thank Sisters M Coyle, N Fosbrook, and S Thompson and the nursing staff of the paediatric wards at Monsall Hospital for their efficient and untiring contribution in making the study run smoothly. Mr Andrzej Makowski, of the department of statistics, North West Regional Health Authority, gave expert help with the statistical data. months after a six month course of carbimazole. Samples were stored in liquid nitrogen until completion of the study, when they were thawed and all samples from each patient analysed within the same assay using mouse monoclonal antibodies to human cell subsets and a fluorescence activated cell sorter. Proportions of cytotoxic/suppressor (OKT8) positive cells before treatment (mean 17 4(SEM 0O8)%) were significantly lower (p <0 001) than those in normal controls (29 8 (19)%; n--10) and returned to normal by the end of treatment. In contrast, the proportions of activated T cells (OKIa-OKM1) were significantly raised before treatment as compared with normal (14 4 (0-6)% versus 4-6 (0-8)%; p <0 001) and fell to normal by the end of treatment. Proportions of OKT3 and OKT4 positive T cells remained unchanged throughout treatment and in the succeeding 12 months. In patients who relapsed after treatment there was a rise in the proportion of activated T cells and a fall in OKT8 positive T cells, which returned towards normal with retreatment.
The explanation for the alterations in numbers of circulating T cells remains to be determined but they may provide a means for predicting more accurately the outcome of Graves' disease after treatment with carbimazole.
